Shin, Woon-Seob Oh, Sangtae An, Sung-Wan Park, Gab-Man Kwon, Daeho Ham, Jungyeob Lee, Seokjoon Park, Byong-Gon 2024-01-20T12:33:26Z 2024-01-20T12:33:26Z 2021-09-05 2013-04 1537-1891 https://pubs.kist.re.kr/handle/201004/128198 A specific blocker of L-type Ca2+ channels may be useful in decreasing arterial tone by reducing the open-state probability of L-type Ca2+ channels. The aim of the present study was to evaluate the farnesylacetones, which are major active constituents of Sargassum siliquastrum, regarding their vasodilatation efficacies, selectivities toward L-type Ca2+ channels, and in vivo antihypertensive activities. The application of 5E-(famesylacetone 311) or 5Z-farnesylacetone (farnesylacetone 312) induced concentration-dependent vasodilatation effects on the basilar artery that was pre-contracted with depolarization and showed an ignorable potential role of endothelial-derived nitric oxide. We also tested farnesylacetone 311 or 312 to determine their pharmacological profiles for the blockade of native L-type Ca2+ channels in basilar arterial smooth muscle cells (BASMCs) and ventricular myocytes (VMCs), cloned L-(alpha 1C/beta 2a/alpha 2 delta), N-(alpha 1B/beta 1b/alpha 2 delta), and T-type Ca2+ channels (alpha 1G, alpha 1H, and alpha 1I). Farnesylacetone 311 or 312 showed greater selectivity toward the L-type Ca2+ channels among the tested voltage-gated Ca2+ channels. The ranked order of the potency for farnesylacetone 311 was cloned alpha 1C L-type (BASMC) L-type (VMCs)>alpha 1B>alpha 1H>alpha 1I>alpha 1G and that for famesylacetone 312 was cloned alpha 1C L-type (BASMCs) L-type (VMCs)>alpha 1H>alpha 1G>alpha 1B>alpha 1I. The oral administration of the famesylacetone 311 (80 mg/kg) conferred potent, long-lasting antihypertensive activity in spontaneous hypertensive rats, but it did not alter the heart rate. (C) 2013 Elsevier Inc. All rights reserved. English ELSEVIER SCIENCE INC SPONTANEOUSLY HYPERTENSIVE-RATS HIGH BLOOD-PRESSURE SMOOTH-MUSCLE-CELLS GATED ION CHANNELS RESISTANCE ARTERIES SYMPATHETIC NEURONS CA2+ CHANNELS WISTAR-KYOTO PHARMACOLOGY DEPOLARIZATION 5E- and 5Z-farnesylacetones from Sargassum siliquastrum as novel selective L-type calcium channel blockers Article 10.1016/j.vph.2013.02.001 1 VASCULAR PHARMACOLOGY, v.58, no.4, pp.299 - 306 VASCULAR PHARMACOLOGY 58 4 299 306 scie scopus 000317166700007 2-s2.0-84875368253 Pharmacology & Pharmacy Pharmacology & Pharmacy Article SPONTANEOUSLY HYPERTENSIVE-RATS HIGH BLOOD-PRESSURE SMOOTH-MUSCLE-CELLS GATED ION CHANNELS RESISTANCE ARTERIES SYMPATHETIC NEURONS CA2+ CHANNELS WISTAR-KYOTO PHARMACOLOGY DEPOLARIZATION Farnesylacetones L-type calcium channel Vasodilatation Hypertension